drugset
drugset / Trial / NCT06217796

Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation

NCT06217796 ↗

Phase 4 Completed 30 enrolled Eyenovia Inc.
NaSingle-groupOpen-labelDiagnostic

Summary

Subjects will receive ½ of the approved dose of MydCombi to determine the dilation curve with the reduced dose.

Timeline

Start
2023-11-28
Primary completion
2024-01-09
Completion
2024-01-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenylephrine Small molecule 2.5 % Other
Subject tropicamide Small molecule 1 % Other

Indications

No indication recorded.